ellaOne (ulipristal acetate)
Pronunciation: you-lih-PRISS-tal AS-eh-tate.
- Generic name
- ulipristal acetate
- Drug class
- Selective progesterone receptor modulator (emergency contraceptive)
- Form
- Tablet (30 mg, single dose)
- Route
- Oral
- Legal status
- Available without a prescription from a pharmacist in some countries (e.g. UK, EU, Australia); prescription-only in others (e.g. Canada)
Availability and supply rules vary by country
Trade names by country: United States · United Kingdom · Canada · Australia
Australia: EllaOne (5) · Full directory
What ulipristal acetate is and how it works
Ulipristal acetate (ella/ellaOne) is a single-dose emergency contraceptive tablet taken after unprotected sex or a contraceptive failure (such as a missed pill or a broken condom), to help prevent pregnancy. It works mainly by delaying or preventing ovulation (the release of an egg). (1) (2)
It is effective for up to 120 hours (5 days) after unprotected intercourse, but works best the sooner it is taken. It is not intended for routine or repeated use as a regular contraceptive method, and it does not protect against sexually transmitted infections.
Mechanism of action: how ulipristal acetate works
Ulipristal acetate is a selective progesterone receptor modulator with partial agonist/antagonist activity at the progesterone receptor. Its primary contraceptive mechanism is inhibition or delay of ovulation via disruption of the LH surge, even in the late follicular phase, which distinguishes it from levonorgestrel (whose efficacy declines more sharply once the LH surge has begun). (1) (2)
What ulipristal acetate is used for
Emergency contraception
Taken as a single dose to help prevent pregnancy after unprotected sex or a known or suspected contraceptive failure, as soon as possible and no later than 120 hours (5 days) afterward. There are no efficacy data for use beyond 120 hours. (1) (2)
Before taking ulipristal acetate
Do not take / not appropriate for
- Do not take ulipristal acetate if you know or suspect you are already pregnant -- it will not end an existing pregnancy. (all countries) (1) (2)
- Do not take it if you have had a serious allergic reaction to ulipristal acetate before. (United Kingdom, European Union) (2)
- Do not rely on ulipristal acetate as your regular method of contraception, and do not take it more than once in the same menstrual cycle without checking with a pharmacist or clinician. (all countries) (1) (2)
Tell your clinician about
- Whether you have taken any hormonal contraceptive (the combined pill, progestogen-only pill, patch, ring, injection, implant, or hormonal IUD) recently, or plan to start one soon -- timing matters for both medicines to work properly.
- Whether you take any medicine for epilepsy, tuberculosis, HIV, or a fungal infection, or St. John's Wort -- some of these can make ulipristal acetate less effective.
- Whether you are breastfeeding.
- Whether you have severe asthma controlled with oral steroids, or severe liver problems.
- If you have had unprotected sex earlier in the same cycle, since this may affect suitability.
How to take ulipristal acetate
- Take the single tablet by mouth as soon as possible after unprotected sex or a contraceptive failure -- effectiveness may lessen the longer you wait, and there is no efficacy data beyond 120 hours (5 days).
- Can be taken with or without food, at any point in your menstrual cycle.
- If you vomit within 3 hours of taking it, contact a pharmacist or clinician -- another dose may be needed.
- Use a barrier method (such as condoms) for the rest of your current cycle, since ulipristal acetate does not protect against pregnancy from any further unprotected sex.
- Do not start or restart a hormonal contraceptive (the pill, patch, ring, injection, or implant) until at least 5 days after taking ulipristal acetate -- ask a pharmacist or clinician for guidance on timing.
Procedures and treatment changes
Tell the treating team before surgery, procedures, or any medicine change. Do not alter treatment without the responsible clinician. (1) (2) (3) (4) (5) (6)
Missed dose
This medicine is taken as a single dose, so there is no ongoing dosing schedule to miss. If you are unsure whether you took it correctly or in time, contact a pharmacist or clinician promptly.
Overdose
Taking more than one tablet is not expected to improve effectiveness and is not recommended. If you are concerned you have taken too much, contact a pharmacist, clinician, or poison-control service. (2)
Side effects
Side effects and their urgency vary; report severe, persistent, or concerning symptoms.
Headache.
What to notice: Headache.
What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1) (2)
Nausea.
What to notice: Nausea.
What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1) (2)
Abdominal (stomach) pain.
What to notice: Abdominal (stomach) pain.
What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1) (2)
Painful periods (dysmenorrhoea) and menstrual irregularities, including a delayed period.
What to notice: Painful periods (dysmenorrhoea) and menstrual irregularities, including a delayed period.
What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1) (2)
Fatigue and dizziness.
What to notice: Fatigue and dizziness.
What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1) (2)
Serious warnings
Signs of ectopic pregnancy — serious
Symptoms: Severe or persistent lower abdominal (stomach) pain.
Action: Seek prompt medical attention -- your clinician will want to check for ectopic pregnancy, especially if you have risk factors such as a previous ectopic pregnancy, tubal surgery, or pelvic infection. (1)
Period more than 7 days late — high caution
Symptoms: Your period does not arrive within about a week of when expected after taking ulipristal acetate (periods can be delayed by 20 or more days in some people).
Action: Take a pregnancy test and contact a pharmacist or clinician to rule out pregnancy. (1) (2)
Signs of a serious allergic reaction — emergency
Symptoms: Swelling of the face, lips, tongue, or throat; difficulty breathing; widespread rash or hives.
Action: Seek emergency medical help immediately. (2)
Interactions
- Strong CYP3A4-inducer medicines (such as rifampicin, certain anti-seizure medicines including phenytoin and carbamazepine, and St. John's Wort) can markedly reduce how well ulipristal acetate works. If you have used one of these recently, ask a pharmacist about a copper IUD as a more reliable emergency contraception option instead. (2) (1)
- Hormonal contraceptives (the combined pill, progestogen-only pill, patch, ring, injection, or implant), including levonorgestrel-based emergency contraception, can reduce ulipristal acetate's own effectiveness if taken too close together -- do not start or resume hormonal contraception until at least 5 days after taking ulipristal acetate, and avoid combining it with levonorgestrel emergency contraception in the same cycle. (1) (2)
- Strong CYP3A4 inhibitors (such as itraconazole or ketoconazole) can raise ulipristal acetate levels in the body. (1)
Pregnancy, breastfeeding, kidney/liver function, age
Pregnancy
Contraindicated -- ulipristal acetate is not for use during an existing pregnancy and will not end one. There is insufficient data to confirm safety if taken inadvertently during early pregnancy. (1) (2) (3) (4) (5) (6)
Breastfeeding
Ulipristal acetate and its active metabolite pass into breast milk in small amounts. The UK SmPC advises not breastfeeding for one week after taking it; the US label estimates a breastfed infant would receive roughly 0.8-1% of the maternal weight-adjusted dose. Discuss timing with a pharmacist or clinician. (1) (2) (3) (4) (5) (6)
Children
Indicated for women and girls of reproductive age who have started menstruating; not applicable to those who have not yet reached puberty. (1) (2) (3) (4) (5) (6)
Elderly
Not applicable -- indicated for use during reproductive years. (1) (2) (3) (4) (5) (6)
Hepatic_impairment
Use with caution in severe liver impairment, per the sources reviewed; discuss with a pharmacist or clinician. (1) (2) (3) (4) (5) (6)
Renal_impairment
No specific dose adjustment identified in the sources reviewed for this dossier. (1) (2) (3) (4) (5) (6)
Source_ids
US-DAILYMED-ELLA-2026,UK-EMC-ELLAONE-2026 (1) (2) (3) (4) (5) (6)
Monitoring
Before starting
- Confirm timing since unprotected intercourse is within 120 hours
- Ask about recent or planned hormonal contraceptive use
- Ask about medicines that induce CYP3A4
During treatment
- Watch for severe or persistent lower abdominal pain (possible ectopic pregnancy).
- Take a pregnancy test if your period is more than about 7 days late.
- Use a barrier method until your next period, and get guidance on when to resume hormonal contraception.
Storage
Store below 25 degC, protected from light and moisture, in the original packaging, out of reach of children.
Professional information
Clinician/pharmacist-facing context only, sourced from the current US FDA ella prescribing information and the UK EMC ellaOne SmPC; verify against the current full label before dispensing or prescribing.
United States / United Kingdom / European Union / Canada / Australia
Indication: Emergency contraception
Dose summary: Single 30 mg oral tablet, as soon as possible and no later than 120 hours (5 days) after unprotected intercourse or contraceptive failure; consider re-dosing if vomiting occurs within 3 hours.
Renal context: No specific renal dosing guidance identified in the sources reviewed. (1) (2)
Hepatic guidance
Use with caution in severe hepatic impairment per the sources reviewed; specific dose-adjustment data were not identified.
Overdose note
No specific antidote; single supratherapeutic doses have not shown a distinct toxicity signal in the sources reviewed, but re-dosing beyond label guidance is not recommended. (1) (2)
Frequently asked questions
How long after unprotected sex can I take ulipristal acetate?
Up to 120 hours (5 days) afterward, but it works best the sooner you take it. There is no data on how well it works if taken later than 120 hours. (1) (2)
Can I take the contraceptive pill and ulipristal acetate together?
Not at the same time. Hormonal contraceptives can reduce how well ulipristal acetate works, so you should wait at least 5 days after taking it before starting or restarting a hormonal contraceptive, and use a barrier method (like condoms) in the meantime. (1) (2)
Is ellaOne available in the US, UK, Europe, Canada, and Australia?
Yes, under the brand names ella (United States, Canada) or ellaOne (United Kingdom, European Union, Australia). It is not approved for emergency contraception in New Zealand -- ulipristal acetate is only approved there under a different brand (Esmya) for treating uterine fibroids, a completely different use. (1) (2) (3) (4) (5) (6)
Does anything make ulipristal acetate less effective?
Yes. Strong CYP3A4-inducer medicines (such as rifampicin, some anti-seizure medicines, and St. John's Wort) can markedly reduce its effectiveness -- a copper IUD may be a better option if you have used one of these recently. Recently used or soon-to-be-started hormonal contraceptives can also interfere with it. (2) (1)
What is the mechanism of action of ulipristal acetate?
Ulipristal acetate is a selective progesterone receptor modulator with partial agonist/antagonist activity at the progesterone receptor. Its primary contraceptive mechanism is inhibition or delay of ovulation via disruption of the LH surge, even in the late follicular phase, which distinguishes it from levonorgestrel (whose efficacy declines more sharply once the LH surge has begun). (1) (2)
What is the generic name of ellaOne (ulipristal acetate)?
References
- ella (ulipristal acetate) tablet, for oral use -- full prescribing informationU.S. Food and Drug Administration / DailyMed (NIH), full prescribing information · United States · accessed 2026-07-30 · source 1
- Ulipristal 30 mg film-coated tablets (ellaOne) -- Summary of Product Characteristicselectronic medicines compendium (emc), United Kingdom -- HRA Pharma UK · United Kingdom · accessed 2026-07-30 · source 2
- ellaOne (ulipristal acetate) -- EPAR and CHMP prescription-status variationEuropean Medicines Agency (EMA) -- EPAR for ellaOne · European Union · accessed 2026-07-30 · source 3
- ella (ulipristal acetate) Product MonographHealth Canada product monograph, AbbVie Corporation · Canada · accessed 2026-07-30 · source 4
- EllaOne ulipristal acetate 30 mg tablet blister pack -- ARTG entry 219535Therapeutic Goods Administration (TGA), Australia / healthdirect.gov.au (Australian Government consumer health service) · Australia · accessed 2026-07-30 · source 5
- Ulipristal acetate New Zealand regulatory status -- approved only as Esmya for uterine fibroids, not for emergency contraceptionMedsafe (New Zealand regulator) -- via independent clinical/regulatory summary · New Zealand · accessed 2026-07-30 · source 6
Brand names by country
Single-ingredient ulipristal acetate names are shown separately by country. Product availability, strengths, and supply rules can change; combination products are not included here.
Priority countries
United States
- Ella30 mg · a-s medication solutions
United Kingdom
- ellaOne (2)MHRA licensed emc smpc confirmed pharmacy OTC · 30 mg · HRA Pharma UK
Canada
- FIBRISTAL
- ELLA
Australia
- EllaOne (5)TGA ARTG registered 2015-03-06 confirmed pharmacist only S3 · 30 mg · ARTG entry 219535
View brands in additional countries.
European Union
ellaOne (3)